In healthcare dossiers, these three dimensions are often treated separately. Yet it is their articulation that produces a credible decision.
Cost-effectiveness answers a value question
Cost-effectiveness analysis aims to determine whether the benefits of an intervention justify the resources it requires. It is central to understanding the health return on investment.
But on its own, it does not always tell whether the system can absorb that investment.
Budget impact answers an affordability question
Even a highly efficient intervention may become problematic if adoption generates a major short-term budget shock. Budget impact analysis brings the decision back to a much more concrete financing horizon.
It helps anticipate volumes, expenditure trajectories, and room for maneuver.
HTA connects evidence to institutional decision-making
Health technology assessment is not only about compiling results. It places clinical, economic, organizational, and sometimes ethical evidence into a public or institutional decision framework.
That is what connects theoretical value, financial sustainability, and the real objectives of the system.
Without that articulation, dossiers may be technically impressive yet remain of limited use for real-world decisions.
The common mistake: treating these dimensions in silos
In many dossiers, clinical logic, economic logic, and budget logic evolve in parallel without true integration. The result is analysis that may be correct, but far less persuasive when final trade-offs are made.
A more mature approach is to make these dimensions interact from the moment the dossier is designed, so that each result directly informs the decision question.